The MM+M Podcast is Medical Marketing + Media’s show about healthcare marketing writ large. Each week, hosts Marc Iskowitz and Larry Dobrow — senior editors at the publication — interview the executives commercializing brands, the agencies supporting launches, and other fascinating guests from in and around the industries of pharma, biotech, med-tech ad-tech and health media.
MM+M Podcast 5.31.23: Richards says Bayer pharma brands have activated on addressable TV
Marc Iskowitz interviews Bayer’s Glenniss Richards about how the pharma unit is testing native and video ads, Lecia Bushak recaps a White House proposal aiming to increase transparency around Medicaid prescription drug costs, and more.
MM+M Podcast 5.26.23: Brigham Hyde says doctors can’t trust ChatGPT
Jack O’Brien interviews Atropos Health CEO and co-founder Brigham Hyde, Lecia Bushak gives a rundown on some newly introduced bills aimed at reining in fentanyl and Jack reports on a skincare brand’s apology over a TikTok influencer promo.
DTC Dialogues: Paul Theisen, CEO, Populus Media
MM+M’s Stephen Madden speaks with Paul Theisen, CEO, Populus Media, about how the pandemic provided the “mother of all use cases” for point-of-care media in telehealth and more.
MM+M Podcast 5.17.23: ‘No quick solution’: Genentech’s Highsmith talks progress, challenges on road to DE&I
Jack O’Brien interviews Quita Highsmith, Genentech’s chief diversity officer, about findings from the biotech’s third annual D&I report. Lecia Bushak explains why the DEA is extending pandemic-era telehealth flexibility for accessing controlled substances.
Insight unlocks a new world of content in the human journey
Relevancy, trust, ease and empathy are critical content traits when engaging individuals managing a condition.
MM+M Podcast 5.11.23: Trivia Frazier drives diversity in biotech
Marc Iskowitz interviews Trivia Frazier, a 2023 Woman of Distinction, about promoting diversity in biotech. Lecia Bushak recaps FDA’s adcomm vote on over-the-counter birth control and Jack O’Brien cues up three items trending on social media.
MM+M Podcast 5.3.23: Patrick Dempsey calls for more empathy in cancer care
Marc Iskowitz interviews Patrick Dempsey about the Grey’s Anatomy star’s cancer advocacy, Lecia Bushak reports on the bipartisan push to reform PBMs and Jack O’Brien briefs Pinterest’s latest mental health campaign.
Leading company-wide omnichannel evolution from the brand and becoming a change champion
How can marketing and omnichannel leaders deliver the kind of amazing customer experiences and digital capabilities we expect as consumers to our HCP and patient customers?
MM+M Podcast 4.26.23: What streamers want from health brands, Medicare’s insolvency, and pharma shuns TikTok
In an interview with Roku’s Eric Lloyd, Lecia Bushak compares benefits of streaming vs. linear TV for health brands. Lecia also explains Medicare’s financing problem, and how a new bill could help. And Jack O’Brien recaps a study suggesting drugmakers aren’t taking advantage of some social media platforms.
3 for 2023: Trends that will define HCP engagement in 2023
2023: Tighter budgets, increased policy pressures, shifting treatment dynamics. How will engagement with HCPs evolve within 2023 and what will it take to succeed.
MM+M Podcast 4.20.23: The high stakes of cannabis marketing and the uproar over ‘DIY dentistry’
Jack O’Brien interviews Curaleaf’s Kate Lynch about challenges and opportunities of cannabis marketing. Lecia Bushak reviews FDA changes to the use of the COVID-19 bivalent mRNA vaccines. And O’Brien explains the uproar over the social “DIY dentistry” trend.
MM+M Podcast 4.12.23: Not your father’s online symptom checker, dueling abortion pill rulings, and the Red Cross-Snoopy collab
Marc Iskowitz interviews AdPrime’s Barbara Read about a new online symptom checker leveraging ChatGPT. Lecia Bushak makes sense of the conflicting abortion pill rulings. And Jack O’Brien discusses the collaboration that helped Snoopy go viral on TikTok.
MM+M Podcast 4.4.23: The new drug-price ‘chessboard,’ Senate scrutiny on PBMs, and is ‘face taping’ a benign TikTok fad?
Marc Iskowitz interviews Indegene’s Jack Mycka about recent drug-price developments. Lecia Bushak recaps the Senate hearing on PBMs, as well as the White House’s response to a recent ACA ruling. And Jack O’Brien reviews “face taping,” an anti-aging experiment turned TikTok fad.
MM+M Podcast 3.30.23: Verily talks digital trial recruiting, Narcan goes OTC and the Meta Pixel riles more patients
Marc Iskowitz speaks with Alix Hart, Transform keynote, for the Verily CMO’s take on connecting patients to clinical trials. Lecia Bushak recaps two important policy moves made by FDA this week. And Jack O’Brien discusses the latest class action lawsuits from patients involving Meta’s data pixel.
MM+M Podcast 3.23.23: Pharma forecasting done right, a mifepristone explainer, and Ted Lasso goes to Washington
Marc Iskowitz interviews Mycovia Pharma’s Tiffany Ahlers and Propensity4’s Sese Abhulimen about pharma forecasting. Lecia Bushak explains the court case involving abortion pill mifepristone. And Jack O’Brien recaps a trip to the White House by the cast of hit show Ted Lasso to discuss mental health.
MM+M Podcast 3.16.23: Infusing ChatGPT into med comms, expanding Medicare drug-price negotiation, and exploring demand for a male contraceptive
Jack O’Brien interviews Inizio Medical’s Matt Lewis about using ChatGPT in med comms. Lecia Bushak recaps a Biden plan to double the number of drugs eligible for Medicare price negotiation. And Jack explore the pent-up demand for non-hormonal male contraceptives.
MM+M Podcast 3.9.23: A survival guide for era of tighter marketing budgets, East Palestine’s messaging lessons, and Novak Djokovic’s COVID-19 vax row bounces back into spotlight
Surviving tighter marketing budgets, messaging lessons from East Palestine, and row over Novak Djokovic’s vax status bounces back.
MM+M Podcast 3.2.23: Yankee great Bernie Williams considers rare disease advocacy his biggest hit, and Woody Harrelson takes (another) shot at the drug industry
In honor of Rare Disease Day, Marc Iskowitz interviews Bernie Williams about his patient advocacy and Jack O’Brien explains why Woody Harrelson’s SNL monologue was no laughing matter.
MM+M Podcast 2.23.23: Millennial managers speak, Moderna changes its tune, and a patient’s encounter with a pharmacist goes viral
Marc Iskowitz interviews members of MM+M’s 2023 class of 40 Under 40, Lecia Bushak analyzes Moderna’s COVID-19 vaccine about-face, and Jack O’Brien explains how a patient’s attempt to get the COVID shot went viral after a pharmacist revealed her moral objection to administering the shot.
MM+M Podcast 2.16.23: Daniel Kraft imagines ‘convergent’ future, Medicaid mulls grocery coverage, and a show sparks fears of zombie fungus apocalypse
Marc Iskowitz talks with Dr. Daniel Kraft about the potential of generative AI and gene sequencing, Lecia Bushak explains the fed’s “food as medicine” shift, and Jack O’Brien talks about the risk of a zombie fungus apocalypse.
